Device designed to treat a leading cause of blindness
A new investigational device, invented by a UA professor, could dramatically change the way the degenerative disease is treated.
(Medical Xpress) -- Every year, more than 200,000 people in the U.S. are diagnosed with Wet Age-Related Macular Degeneration, a leading cause of blindness in Americans age 60 or older. There is no known cure for the disease, which can lead to partial or complete vision loss.
But a new investigational device, invented by a University of Arizona professor, could dramatically change the way the degenerative disease is treated.
Wet Age-Related Macular Degeneration, or Wet AMD, occurs when abnormal blood vessels begin to grow behind the eye's macula, located in the center of the retina, and leak fluid that causes the macula to shift from its normal position and become damaged. It is more serious than the more common Dry Age-Related Macular Degeneration, which occurs when light-sensitive cells in the macula break down, blurring central vision.
One of the most common treatments for Wet AMD is repeated injections into the eye of anti-VGEF (anti-Vascular Endothelial Growth Factor) drugs, designed to slow the growth of abnormal blood vessels.
But those injections, administered as often as once a month for life, can be uncomfortable for patients and are not effective for everyone, said Russell Hamilton, radiation oncology professor and head of the physics section of the UA department of radiation oncology.
So Hamilton set out to find a less invasive way to treat patients that would reduce, or perhaps altogether eliminate, the need for repeated anti-VGEF injections.
His investigational device, which is now in the early stages of human study, is designed to deliver targeted radiation to blood vessel leaks via a small radioactive seed inserted behind the eye. The idea is that targeted radiation will provide a more long-term solution and help increase the effectiveness of initial anti-VGEF injections.
"When you're diagnosed with Wet AMD, you would have the anti-VGEF injection immediately. We're hoping the radiation will then increase the durability of the treatment, so that after the first month patients won't need to be injected again," said Hamilton, who also is a co-founder of Salutaris Medical Devices Inc., a privately held Tucson company founded to develop an investigational ophthalmic treatment for Wet AMD.
The device, about six inches in length, includes a wire with a curved end, designed to fit around the eye. It is inserted over the top of the eye, through a small incision, and moved toward the back of the eye, where it delivers a dose of radiation to repair troublesome leaks.
Requiring only a small incision, the procedure is minimally invasive and is intended to be done under local anesthesia in approximately 15 minutes in a physician's office or outpatient setting.
Researchers say it could be a safer, simpler alternative to external radiation, which also has been used to treat Wet AMD, and to other investigational treatments that involve penetration of the eye to deliver radiation.
"If this is proven in a larger trial, it's going to be game changing," said Dr. Baldassarre Stea, professor and chairman of the UA department of radiation oncology and co-principal investigator of the device study, along with Dr. Reid Schindler, clinical associate professor in the UA department of ophthalmology and vision science.
"Not only is it going to be beneficial from an economic point of view, in an era where resources are limited and the injections cost $2,000 a shot, but the quality of life of the patient will also be impacted," Stea said. "You regain your vision better, you don't have to go back and forth to the ophthalmologist every month to get the injection, and you save money and aggravation."
Hamilton said he began working on his device after learning of the successful use of radiation to treat melanoma of the eye.
In January, the results of a Phase 1 study to evaluate the safety of the device were shared during Retina Meeting 2012. Of the six test subjects treated with the device, all saw improvement in vision, none experienced additional vision loss and three were able to discontinue their anti-VGEF injections. Furthermore, there were no reported "Serious Adverse Events" or "Unanticipated Adverse Device Effects."
Additional studies are expected to get under way later this year. Stea said if those go well, FDA approval for the device could happen within a few years.
Provided by University of Arizona
- Vision loss slowed by encapsulated cell therapy Apr 07, 2011 | not rated yet | 0
- Study finds lack of VEGF can cause defects similar to dry macular degeneration Nov 02, 2009 | not rated yet | 0
- Researchers find no difference in drugs for macular degeneration Oct 01, 2010 | not rated yet | 0
- Report shows risk of blindness halved over last decade Jan 19, 2012 | not rated yet | 0
- Study shows daily aspirin intake can lead to blindness Oct 05, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Calculating Steam Pressure in Closed Container
2 hours ago I am trying to calculate the volume of liquid water i need to place in a sealed container in order to obtain 10 psi of steam pressure in that closed...
Learning curve of Electromagnetism?
7 hours ago I'm taking a first year physics course and have been having a little trouble with the basics of newtons laws and forces and whatnot, though nothing...
thin glass in liquid
8 hours ago I have one question about optics because I start interested in it. If an object is placed a distance p from a thin glass lens (index of refraction...
How many joules expended for a push up?
11 hours ago Just wondering if any of you can do the calculation that well approximates the amount of joules expended by a push up.
force to keep the folding doors
11 hours ago Hello, I would like to ask you to calculate the force F, which needed to keep the folding doors in this position. I would like to know what is the...
Confusion regarding direction of kinetic friction on inclined plane.
12 hours ago *please help! * The formula for kinetic friction acting on a sliding body is μkN When the body is sliding with constant velocity down an...
- More from Physics Forums - Classical Physics
More news stories
The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
New research is emphasizing the importance of regular screenings for glaucoma, a disease that deteriorates the optic nerve over time and is a leading cause of irreversible blindness worldwide. The onset of glaucoma is associated ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
The University of Nottingham and Nottingham University Hospitals NHS Trust, have been working with Sony Computer Entertainment Europe (SCEE) to develop special 3-D glasses and games to help treat children ...
Ophthalmology May 08, 2013 | not rated yet | 0
The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service ...
Ophthalmology May 07, 2013 | 5 / 5 (1) | 0
Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, ...
Ophthalmology May 06, 2013 | 3 / 5 (2) | 0 |
10 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
8 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
8 hours ago | not rated yet | 0
19 hours ago | 5 / 5 (1) | 0
20 hours ago | 5 / 5 (1) | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
10 hours ago | 5 / 5 (2) | 0